The EDM Reference Model defines Domain as the discipline a document was created in. Serious organisations run several at once, and each discipline owns its own taxonomy. Most systems model that and enforce none of it.
Regulatory teams often describe their document search as “acting like a filter”. Surprisingly often, it literally is one — matching file names over the page already loaded in the browser.
Audit preparation should not be a three-week fire drill. How continuous readiness scoring, one-click audit packs, and mock inspection mode turn inspection prep into a standing capability.
A pharmaceutical EDMS in 2026 is judged on Part 11 e-signatures, audit trails, and how far it extends beyond regulatory — into quality, clinical, training, and inspection readiness.
Discover how AI-powered EDMS features transform pharmaceutical document management with intelligent duplicate detection, automated summarization, and smart classification for faster regulatory submissions.
Discover how DNXT combines keyword search with AI-powered semantic understanding to help regulatory teams find documents instantly using natural language queries.
In pharmaceutical document management, data security isn’t just important—it’s mission-critical. When sensitive regulatory documents contain proprietary formulations, clinical trial data, and submission strategies worth millions, the last thing you want is that information flowing to external AI providers where you lose control forever. That’s exactly what happens with most AI-powered document solutions. Your confidential regulatory […]
The Hidden Foundation of Regulatory Success When pharmaceutical companies struggle with document chaos, missed deadlines and compliance problems, the answer is rarely just better processes. It is usually how the software itself is built. The DnXT Publisher Suite is assembled from independent parts, each doing one job well — and that choice is what delivers […]
In the high-stakes world of pharmaceutical regulatory compliance, one mismanaged document or overlooked metadata field can derail million-dollar drug approvals. Yet most organizations still struggle with fragmented document management systems that create more problems than they solve. The Hidden Cost of Metadata Mismanagement Every pharmaceutical company knows the pain: submissions delayed because documents can’t be […]
The Hidden Cost of Regulatory Submission Failures Every pharmaceutical company knows the devastating impact of a rejected regulatory submission. Months of work, hundreds of thousands in development costs, and critical market delays—all because of document validation errors that could have been caught before submission. The FDA receives thousands of submissions annually, with validation failures accounting […]
